August 6, 2015 — C.R. Bard has agreed to pay more than $200 million to settle about 3,000 lawsuits filed by women who were injured by vaginal mesh.
Bloomberg reports that the settlement would provide about $67,000 per plaintiff and resolve about 20% of the cases pending against the company.
The deal is better than the $43,000 payout Bard offered in a smaller deal last year, which resolved about 500 cases for $21 million. However, some individuals have been awarded millions.
In 2012, Bard pulled its Avaulta implants off the market after the FDA ordered all manufacturers of vaginal mesh to study rates of erosion, infection, organ damage, and other side effects.
Soon afterward, a jury in California ordered Bard to pay $5.5 million to a woman who was injured by an Avaulta implant. In 2013, a jury in West Virginia awarded $2 million to Donna Cisson, a woman who was injured by Bard’s Avaulta Plus implant. Just days later, the company settled another case for $2 million.
U.S. District Judge Joseph R. Goodwin oversees about 80,000 vaginal mesh lawsuits against various manufacturers. Earlier this year, he asked lawyers to “kick it into high gear” and urged large-scale settlements to avoid “potentially billions of dollars in verdicts.”
Tens of thousands of cases remain pending in state and federal courtrooms around the nation. The litigation has been dragging on since 2011, when the FDA warned that serious complications were “not rare.”
Need a Texas Vaginal Mesh Lawyer?
Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.
Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”
The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $260 million in verdicts and/or settlements. Please use the form below to contact our Texas vaginal mesh lawyers for a free lawsuit review.